Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Historical Holders from Q3 2020 to Q3 2025

Symbol
OM on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
265,957,447
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
176,842
Holdings value
$2,498,949
% of all portfolios
0%
Number of holders
3
Number of buys
2
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Durable Capital Partners LP 9.9% $154,630,808 26,609,101 Durable Capital Partners LP 03 Jan 2025
PFM Health Sciences, LP 9.4% $145,280,000 25,000,000 PFM Health Sciences, LP 10 Mar 2025
PERCEPTIVE ADVISORS LLC 9.5% $32,688,000 5,625,000 Perceptive Advisors LLC 08 Jan 2025
FMR LLC 7% $21,334,153 3,671,213 FMR LLC 31 Dec 2024
VANGUARD GROUP INC 4.96% $15,160,851 2,608,902 The Vanguard Group 31 Dec 2024
Alyeska Investment Group, L.P. 9.61% $9,896,956 1,703,083 Alyeska Investment Group, L.P. 31 Mar 2025

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 176,842 $2,498,949 +$2,006,565 $14.12 3
2025 Q2 34,734 $667,997 +$195,729 $21.73 2
2025 Q1 24,600 $271,908 -$26,758,605 $5.81 2
2024 Q4 21,051,997 $23,361,826 -$3,640,595 $1.11 73
2024 Q3 26,056,953 $17,615,217 -$39,745,792 $0.677 76
2024 Q2 48,587,379 $187,047,220 -$5,223,928 $3.85 118
2024 Q1 50,439,872 $111,971,022 -$20,061,860 $2.22 109
2023 Q4 53,020,613 $286,839,451 -$59,832,469 $5.41 137
2023 Q3 53,632,748 $583,471,975 -$2,257,141 $10.88 150
2023 Q2 52,992,751 $1,158,352,799 +$26,029,052 $21.87 153
2023 Q1 52,028,882 $957,169,691 +$47,145,083 $18.4 159
2022 Q4 49,004,926 $1,265,397,709 +$1,900,384 $25.82 147
2022 Q3 47,753,322 $759,751,328 -$60,798,422 $15.93 131
2022 Q2 48,521,355 $721,230,096 -$163,983,262 $14.86 143
2022 Q1 51,296,045 $2,328,323,118 +$123,798,869 $45.4 147
2021 Q4 48,556,337 $2,237,798,401 -$207,141,965 $46.09 153
2021 Q3 50,674,901 $2,506,125,357 +$215,826,366 $49.44 138
2021 Q2 46,277,397 $2,312,251,576 +$391,010,353 $49.98 126
2021 Q1 38,393,386 $2,088,213,344 +$50,139,442 $54.39 109
2020 Q4 37,414,688 $2,088,176,575 +$69,477,743 $56.84 110
2020 Q3 36,169,665 $1,762,305,350 +$1,762,305,350 $50 85